Glaucoma Management: Infinitely Improved
With two decades of studies behind it, Glaukos’ iStent platform has the longest-term body of evidence of any MIGS procedure
| 2 min read
sponsored by Glaukos
Glaukos founded the MIGS category 20 years ago with the first generation iStent. Continuous innovation since then has resulted in a device portfolio that has revolutionized glaucoma management. With two decades of studies behind it, the iStent platform has the longest-term body of evidence of any MIGS procedure: its safety and efficacy are evident in 200+ peer-reviewed publications – setting the device apart from others.
Given the short learning curve of the iStent inject® W and its broad compatibility with other procedures – including advanced IOL implantation – this device is the first choice for mild-tomoderate glaucoma management. And now, iStent infinite, the latest manifestation of Glaukos’ ground-breaking technology, is designed to provide
surgeons the first standalone, non-ablative MIGS device for patients in need.
Featuring
Ike K. Ahmed, Assistant Professor, Director, Glaucoma & Advanced Anterior Segment Surgery (GAAS) Fellowship, Research Director, Kensington Eye Institute, University of Toronto; Clinical Professor, University of Utah; Director, Division Head, Ophthalmology, Trillium Health Partners, Mississauga; Medical Director, Prism Eye Institute, Mississauga; Co-Medical Director, TLC Mississauga, Ontario, Canada
Christophe Baudouin, Professor of Ophthalmology, chairing the department at Quinze-Vingts National Ophthalmology Hospital in Paris, France
Mark Gallardo, surgeon at El Paso Eye Surgeons, and Adjunct Professor, University of Texas Health Sciences Centre, Houston, Texas, USA
Fritz Hengerer, Director and Chief Medical Officer at the Department of Ophthalmology at Buergerhospital Eye Clinic in Frankfurt, Germany
Leon Walker Herndon, Professor of Ophthalmology, Chief of Glaucoma Division, Duke ophthalmology, Duke University School of Medicine, Durham, North Carolina, USA
Alex Huang, Associate Professor, Alfred Vogt Chair in Ophthalmology at the Shiley Eye Institute, University of California, San Diego, USA
Karsten Klabe, ophthalmic surgeon at Breyer, Kaymak & Klabe Augenchirurgie in Düsseldorf, Germany
Eva Liang, refractive surgeon at Center for Sight, Las Vegas, Nevada, USA
Deborah Ristvedt, ophthalmic surgeon at Vance Thompson Vision, Bozeman, Montana, USA
Thomas Samuelson, founding partner and attending surgeon at Minnesota Eye Consultants, and Adjunct Professor, University of Minnesota, Bloomington, Minnesota, USA
Mitch Shultz, ophthalmic surgeon at Shultz Chang, Northridge, California, USA
Paul Singh, President of The Eye Centers of Racine & Kenosha, Wisconsin, USA
Blake K. Williamson, ophthalmic surgeon at the Williamson Eye Center, Baton Rouge, Louisiana, USA
